Ozempic vs Wegovy: The Inputs That Drive the Decision

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The PlexusDx Education Hub breaks down GLP-1 medicines, weight-management protocols, and the genetic inputs that inform each choice. Open the Peptides & GLP-1 library.

This overview is editorially independent. PlexusDx has no commercial relationship with the manufacturers of any product reviewed here.

A useful Ozempic-versus-Wegovy comparison is less about picking a favorite and more about knowing which inputs actually drive the decision. This overview walks through those layers — active ingredient, indication, evidence, safety, cost, and genetics — using publicly available information as of April 2026 to frame how a clinician reasons across the GLP-1 landscape.

Reading a GLP-1 comparison the right way

Ozempic and Wegovy are two widely-discussed names in a category that has grown well beyond two products. Before comparing them, it helps to separate what is genuinely different from what is shared, because several apparent contrasts dissolve once you look at the molecule underneath each label.

Active ingredient: where Ozempic and Wegovy converge

Ozempic (semaglutide, Novo Nordisk) and Wegovy (semaglutide, Novo Nordisk) are built on the same molecule. For context across the wider family, tirzepatide is a GIP/GLP-1 dual agonist; semaglutide, liraglutide, and dulaglutide are GLP-1-selective; and retatrutide is an investigational triple agonist not FDA-approved as of April 2026. All engage the GLP-1 receptor and modulate gastric emptying, glucose, and satiety.

Indication and dosing as the real divider

The meaningful split between Ozempic and Wegovy is regulatory. FDA approvals by indication include Ozempic for type 2 diabetes (2017), Wegovy (semaglutide 2.4 mg) for chronic weight management (2021), Rybelsus for type 2 diabetes (2019), Mounjaro (2022) and Zepbound (2023, plus obstructive sleep apnea in 2024) for tirzepatide, Trulicity (2014), and Victoza (2010). Indication and labeled dose separate the two semaglutide brands.

Evidence base across the programs

The relevant trials span STEP (semaglutide for weight management), SUSTAIN and SELECT (semaglutide for diabetes and cardiovascular outcomes), SURMOUNT and SURPASS (tirzepatide), SURMOUNT-OSA (sleep apnea), LEAD and LEADER (liraglutide), and AWARD (dulaglutide). Head-to-head data exists for some pairings, such as SUSTAIN 7 and SURPASS-2, but doses and endpoints differ, so per-trial reading is the honest approach.

Safety considerations every candidate shares

All FDA-approved GLP-1 and GIP/GLP-1 agents carry the class boxed warning for thyroid C-cell tumor risk seen in rodent studies and are contraindicated with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Gastrointestinal effects are most common; rare serious events include pancreatitis, gallbladder disease, and dehydration-related kidney injury.

Cost as a moving target

As of April 2026, list prices for the FDA-approved brands range roughly $815–$1,620 per month at U.S. list price (manufacturer published pricing). Because out-of-pocket cost swings with insurance coverage, the FDA indication on the prescription, savings-card eligibility, and compounded-alternative availability through licensed pathways, list price alone rarely predicts what a patient pays.

The genetic layer beneath the decision

The final input is the one most comparisons skip. Variants in FTO (appetite regulation and adiposity set-point), GLP1R (the receptor every GLP-1 compound engages), MC4R (energy balance), and TCF7L2 (glucose homeostasis and GLP-1 secretion) shape the baseline terrain. These pathway-level variants map biology; they do not predict response to any single medication.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, MC4R, and TCF7L2 — so the decision starts from your biology rather than guesswork.

Related reading on PlexusDx: Ozempic Injection Sites, Generic Ozempic, GoodRx Ozempic, Cost of Ozempic without Insurance.

Disclaimer: This article is educational. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, and this page covers the mechanism, evidence, and genetic context that inform any decision to use them. PlexusDx does not sell, prescribe, or recommend any other GLP-1 category peptide beyond semaglutide and tirzepatide, including dulaglutide, liraglutide, retatrutide, and cagrilintide. The Precision Peptide Genetic Test does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start with the biology. Take the Precision Peptide Genetic Test, or explore the Weight Management Protocols.

Frequently Asked Questions about Ozempic and Wegovy

Which factor should carry the most weight in the comparison?

For Ozempic and Wegovy, the labeled indication and dose usually matter most, since both share the semaglutide molecule. Beyond that, evidence for your specific goal, safety fit, cost after coverage, and your genetic baseline all feed the decision. A clinician weighs these together rather than ranking either product in isolation.

Do I need to understand the whole category to choose?

Not entirely, but context helps. Knowing that semaglutide and tirzepatide occupy different receptor branches, and that several brands share active ingredients, prevents confusion when a provider suggests an alternative. This overview aims to give that map so a two-name comparison sits inside the larger landscape.

How does the genetic test factor into the decision?

It supplies the upstream layer. The Precision Peptide Genetic Test analyzes pathway variants such as FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline appetite and energy-balance biology. It does not predict response to Ozempic, Wegovy, or any drug, but it gives you and your provider informed context before committing.

Why can two semaglutide products cost different amounts?

Different brands and indications built on the same molecule carry different list prices, which is why the category spans roughly $815–$1,620 per month. Actual cost still depends on insurance coverage, the prescribed indication, savings-card eligibility, and whether a compounded pathway applies, so the label price is only a starting point.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.